More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic arthritis, according to data published in Therapeutic Advances in Musculoskeletal ...

Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for ...

Staying active can help you manage psoriatic arthritis — as long as you do it right. Avoid these exercise mistakes to keep your joints moving.

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

A recent study reaffirmed the safety and effectiveness of guselkumab, in managing psoriasis and psoriatic arthritis over an extended period of 208 weeks (approximately 4 years). This ...

The chronic skin inflammation in psoriasis is ... Takeda does not have any product approved for the treatment of psoriasis or psoriatic arthritis at the time of publication. TAKEDA and the TAKEDA ...

Founded by 21-year-old Aerin Glazer, Tilt aims to help people with chronic pain and dexterity issues to use makeup with ease.

Understanding the link between gut health and psoriasis opens new avenues for treatment and highlights the need for comprehensive care approaches that encompass both dermatological and gastrointestina ...

Tilt Beauty, a groundbreaking new brand specializing in cutting-edge design and clean formulas launches today exclusively at ...

[2] The group recommended treatment for all aspects of PsA, including peripheral and axial arthritis, skin and nail disease ... of all treatment strategies in psoriatic arthritis.

A large European study finds that TNF inhibitors work differently across joints in psoriatic arthritis, with the shoulder and ...